RLMD

Relmada Therapeutics, Inc.

4 transactions on file, per SEC Form 4 filings.

Shenouda Maged

Chief Financial Officer · 2026-09-10

Bought

$339K

TRAVERSA SERGIO

Chief Executive Officer · 2026-09-10

Bought

$410K

Shenouda Maged

Chief Financial Officer · 2026-09-09

Bought

$505K

TRAVERSA SERGIO

Chief Executive Officer · 2026-09-09

Bought

$418K

Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.

Is RLMD actually a buy?

Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.